Business Wire THERACLION: Last Patient of First SONOVEIN® US Study Has Been Treated MALAKOFF, France, October 17, 2022–Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing a scalable robotic platform for non-invasive ultrasound therapy to treat varicose vein disease, announced at the 2022 AVLS congress in New Orleans, Louisiana (US), on October 14th, that the final patient enrolled in the first SONOVEIN® study in the United States has been treated.
Continue Reading: Ohio State Buckeyes to open season unranked nationally for first time in four years
